DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

MannKind Corp (NASDAQ: MNKD)

3.28 0.20 (6.49%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $3.28 6.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.01
Previous Close $3.08
Daily Range $2.98 - $3.28
52-Week Range $2.98 - $7.88
Market Cap $1.4B
P/E Ratio -9.33
Dividend (Yield) $0.00 (0.0%)
Volume 4,717,306
Average Daily Volume 4,790,851
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

MannKind Cuts Its Headcount, But Will It Matter?

MannKind is laying-off workers to reduce expenses, but without sales growth these cuts may not be enough.

Why Sanofi's Afrezza Marketing Strategy Is Brilliant

Diabetic Investor On MannKind: 'There's A Reason Why So Many People Are Short This Stock'

MannKind: Weekly Data Updates For Prescriptions

3 Biotech Stocks Short-Sellers Have Targeted the Most

These three biotech stocks have bull's-eyes on their backs courtesy of short-sellers.

These Healthcare Stocks Could Be Primed for a Short Squeeze

Should pessimists in these healthcare stocks be shaking in their boots?

3 Investing Myths, Debunked!

Don't be fooled by these common stock market misconceptions

Short Selling: The Hottest U.S.-Listed Stocks From A Securities Lending Perspective

How Sanofi Is Building For MannKind's Afrezza

Do This, Not That -- How to Invest in Healthcare's Biggest Trends

Diabetes and marijuana: which stocks to buy and which are a bust.

See More MNKD News...

MNKD's Top Competitors

MNKD $3.28 (6.49%)
Current stock: MNKD
AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
BIIB $290.35 (1.06%)
Current stock: BIIB